The microarray industry should produce an estimated $1 billion in revenues in 2004, clearly a major milestone to measure progress as the industry reaches its 10th year of existence.

But $1 billion in revenues a commercial revolution does not make. For that, the industry, which this year will see a number of new competitors entering the arena, will have to push the technology to new heights of accuracy and provide a wider set of applications, while enticing new customers.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.